Compile Data Set for Download or QSAR
Report error Found 28 Enz. Inhib. hit(s) with all data for entry = 50020822
TargetD(2) dopamine receptor(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633879(CHEMBL5394961)
Affinity DataKi:  0.200nMAssay Description:Displacement of [3H]-NMSP from D2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633883(CHEMBL5396600)
Affinity DataKi:  0.5nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633884(CHEMBL5422803)
Affinity DataKi:  1.20nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633881(CHEMBL5420183)
Affinity DataKi:  1.30nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetD(2) dopamine receptor(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633878(CHEMBL5408427)
Affinity DataKi:  1.30nMAssay Description:Displacement of [3H]-NMSP from D2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633882(CHEMBL5410397)
Affinity DataKi:  1.5nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633885(CHEMBL5403068)
Affinity DataKi:  1.5nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633879(CHEMBL5394961)
Affinity DataKi:  1.80nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633887(CHEMBL5397729)
Affinity DataKi:  1.90nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633891(CHEMBL5394412)
Affinity DataKi:  3nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633878(CHEMBL5408427)
Affinity DataKi:  4.90nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetD(2) dopamine receptor(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633881(CHEMBL5420183)
Affinity DataKi:  7.30nMAssay Description:Displacement of [3H]-NMSP from D2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633892(CHEMBL5397033)
Affinity DataKi:  9.90nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633894(CHEMBL5433695)
Affinity DataKi:  14nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633896(CHEMBL5409339)
Affinity DataKi:  14nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633886(CHEMBL5435404)
Affinity DataKi:  22nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633880(CHEMBL5432493)
Affinity DataKi:  25nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633888(CHEMBL5395448)
Affinity DataKi:  50nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633895(CHEMBL5417779)
Affinity DataKi:  74nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetD(2) dopamine receptor(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633883(CHEMBL5396600)
Affinity DataKi:  83nMAssay Description:Displacement of [3H]-NMSP from D2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633889(CHEMBL5397703)
Affinity DataKi:  103nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633899(CHEMBL5433407)
Affinity DataKi:  148nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633897(CHEMBL5410304)
Affinity DataKi:  163nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633893(CHEMBL5422674)
Affinity DataKi:  195nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633890(CHEMBL5398629)
Affinity DataKi:  323nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633898(CHEMBL5405092)
Affinity DataKi:  357nMAssay Description:Displacement of [3H]-LSD from 5-HT6 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetD(2) dopamine receptor(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633880(CHEMBL5432493)
Affinity DataKi: >5.00E+3nMAssay Description:Displacement of [3H]-NMSP from D2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetD(2) dopamine receptor(Human)
Ryvu Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633882(CHEMBL5410397)
Affinity DataKi: >5.00E+3nMAssay Description:Displacement of [3H]-NMSP from D2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed